Drugs / Motireb
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02831543 | Apr 2016 → Jan 2017 | dyspepsia | IlDong Pharmaceutical Co Ltd | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Motireb | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02831543 ↗ |